SCHEMBL4725757

SCHEMBL4725757

NS(=O)(=O)c1cccc([AsH]c2ncc3cccc(O)c3n2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 5/20 0.39
CA1 P00915 3/20 0.39
KDM4E B2RXH2 4/20 0.38
ALOX12 P18054 1/20 0.38
GLO1 Q04760 3/20 0.37
ROCK1 Q13464 1/20 0.36
CA12 O43570 3/20 0.36
CA9 Q16790 3/20 0.36
CA4 P22748 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CDK8 P49336 1/20 0.35
LMNA P02545 1/20 0.35
PLAU P00749 1/20 0.34
NCF1 P14598 1/20 0.34
PIM1 P11309 1/20 0.34
CCNT1 O60563 1/20 0.33
CDK1 P06493 1/20 0.33
CCNB1 P14635 1/20 0.33
CDK9 P50750 1/20 0.33
CA6 P23280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632161 0.73 CDK1 (0.59) ROCK1PIM1CCNT1CDK1CCNB1
SCHEMBL1633147 0.68 CDK1 (0.53) CA2CA1CA12CA9CA4
SCHEMBL1041168 0.66 PLAU (0.55) KDM4EALOX12PLAUNCF1PIM1
SCHEMBL3531193 0.65 KDM4E (0.53) KDM4EALOX12LMNAPLAUNCF1
SCHEMBL13313248 0.64 KDM4E (0.47) KDM4EALOX12LMNAPLAUNCF1
SCHEMBL3246319 0.63 KDM4E (0.46) KDM4EALOX12LMNAPLAUNCF1
SCHEMBL3243440 0.62 PIM1 (0.49) KDM4EALOX12LMNAPLAUNCF1
SCHEMBL13313228 0.62 CYP1A2 (0.46) KDM4EALOX12LMNAPLAUNCF1
SCHEMBL3246711 0.62 PIM1 (0.56) KDM4EALOX12LMNAPLAUNCF1
SCHEMBL27640664 0.62 PLAU (0.44) KDM4EALOX12LMNAPLAUNCF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2004615-A2 QUINAZOLINES FOR PDK1 INHIBITION Novartis AG (CH) 2008-12-24 EP disclosed
WO-2007117607-A2 QUINAZOLINES FOR PDK1 INHIBITION NOVARTIS AG (CH) 2007-10-18 WO disclosed